Evidence map›Paper›PMID 38558931›Full record

ArticleiScience2024

TRIF-IFN-I pathway in

Prerna Bali, Ivonne Lozano-Pope, Jonathan Hernandez, Monica V Estrada, Maripat Corr, Michael A Turner, Michael Bouvet, Christopher Benner, Marygorret Obonyo

Open access · goldAbstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. The intersection ofFrontiers in cellular and infection microbiology · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Prerna BaliDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Ivonne Lozano-PopeDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Jonathan HernandezDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Monica V EstradaMoores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Maripat CorrDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Michael A TurnerDepartment of Surgery, University of California, San Diego, La Jolla, CA, USA.
Michael BouvetMoores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Christopher BennerDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Marygorret ObonyoDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
University of California San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS R25 AI147376NIDDK NIH HHS P30 DK120515
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological sciencesCancerClinical microbiologyMicrobiology

Identifiers

PMID38558931
PMCPMC10981133
OpenAlexW4392580372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.